Dynavax Technologies
Dynavax Technologies

Dynavax Technologies

hand in laptop pointing to email icon

Your dream job…could be 1 update away

Dynavax Technologies Careers, Jobs, and Salary Information

Find High Paying Jobs and Compensation Information at Dynavax Technologies

Dynavax Technologies Corporation is a biopharmaceutical company focused on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Dynavax discovers and develops novel vaccines and immuno-oncology therapeutics. The Company's development programs are focused on vaccines for hepatitis B, influenza, and COVID-19, as well as cancer immunotherapy. Dynavax's lead product candidate is HEPLISAV-B, a hepatitis B vaccine for adults. The Company's other products include SD-101, an investigational cancer immunotherapeutic that is in Phase 2 studies, and DV281, an investigational TLR9 agonist that is in Phase 1 studies. Dynavax is headquartered in Berkeley, California.

Snapshot

Employees311
Market Cap$1.3 billion
Revenue$46.5 million
5 Year Trendarrow trend up+108.9%
Net Income-$75.2 million
NASDAQDVAX
Founded1996
pie chartAnnual Report
stats icon
Total value of jobs:
$5,562,597
stats icon
Average Pay:
$173,831
stats icon
% Masters:
71%